Abstract:BACKGROUND: Current studies have demonstrated that disintegrin and metalloproteinase 17 (ADAM17) plays a critical role in the pathogenesis of sepsis. MicroRNA (miR)-145 is known to control immune responses as an anti-inflammatory modulatory molecule. However, a fundamental understanding of how miR-145 regulates ADAM17 and, more broadly, sepsis-induced inflammatory response remains unknown.METHODS: We used western blotting and quantitative real-time PCR (qRT-PCR) to measure expression levels of ADAM17 and miR-145. Enzyme-linked immunosorbent assays (ELISA) were performed to measure cytokine production. To determine if ADAM17 is a target gene of miR-145, bioinformatics analyses and luciferase reporter assays were conducted. The impacts of ADAM17 and miR-145 on sepsis-induced inflammatory responses were accessed <i>in vitro</i> using human umbilical endothelial cells (HUVECs) treated with lipopolysaccharide (LPS). Sepsis-induced inflammatory response was measured <i>in vivo</i> using a polymicrobial septic mouse model induced by cecal ligation and puncture (CLP) with pre-injection of a miR-145 agomir.RESULTS: In HUVECs treated with LPS, miR-145 expression was downregulated and miR-145 negatively regulated ADAM17 expression through direct binding to the ADAM17 transcript 3'-UTR. MiR-145 overexpression markedly reduced LPS-induced inflammatory cytokine production by targeting ADAM17 in HUVECs. In comparison to CLP-induced septic mice treated with a control agomir, treatment with a miR-145 agomir significantly reduced the expression of ADAM17, numerous downstream cytokines such as IL-6, TNF-α, IL-1β and MCP-1, and the endothelial injury factors ICAM-1, VCAM-1. The miR-145 agomir also alleviated acute lung and kidney injury and improved the survival rate of septic mice.CONCLUSIONS: This study showed that miR-145, by specifically targeting ADAM17, negatively regulates sepsis-induced inflammatory responses and vascular endothelial injury, and ultimately improved organ injury and survival during sepsis. The underlying mechanism for the regulation of ADAM17 expression by miR-145 and sepsis-induced inflammatory reactions may offer sepsis patients a novel therapeutic option.

ADAM10-a "multitasker" in sepsis: focus on its posttranslational target

The Emerging Role of Adaptor Proteins in Regulating Innate Immunity of Sepsis

Research advance in the function of a disintegin and metalloprotease 10

MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17

Regulation of ADAM10 activity through microdomain-dependent intracellular calcium changes

An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases

Molecular Switch In Human Diseases-Disintegrin And Metalloproteinases, Adam17

Defensins and Sepsis

Defensins and sepsis.

REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS

Research Advances of Cationic Antimicrobial Peptides in the Immune Response in Sepsis

USP10 regulates macrophage inflammation responses via stabilizing NEMO in LPS-induced sepsis

The Role of ADAM10 in Alzheimer’s Disease

S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury

Basic researches and clinical significance of ADAMTS-1

A Disintegrin and Metalloprotease 10 Expressions Modulate Potential Metastatic and Thrombus Formation in Pancreatic Carcinoma

An integrative proteotranscriptomics approach reveals new ADAM9 substrates and downstream pathways

ADAMs family in kidney physiology and pathology

Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment

The versatile roles of ADAM8 in cancer cell migration, mechanics, and extracellular matrix remodeling